Relationship Between Cardiac 123I-Metaiodobenzylguanidine Imaging and the Transcardiac Gradient of Neurohumoral Factors in Patients With Dilated Cardiomyopathy.
Open Access
- 1 January 2001
- journal article
- Published by Japanese Circulation Society in Japanese Circulation Journal
- Vol. 65 (12), 1041-1046
- https://doi.org/10.1253/jcj.65.1041
Abstract
Cardiac sympathetic nervous function is altered in congestive heart failure (CHF) and the uptake and washout rate of cardiac 123I-metaiodobenzylguanidine (MIBG) are useful markers for evaluating the severity of it. To assess what parameters predict decreased uptake or increased washout rate of MIBG, the concentrations of neurohumoral factor in both the aorta (Ao) and coronary sinus (CS) were measured, as well as hemodynamic parameters by catheterization, in patients with dilated cardiomyopathy (DCM). MIBG imaging was performed within 1 week of cardiac catheterization. Regarding MIBG parameters, the correlation with the transcardiac gradient of norepinephrine (NE), brain natriuretic peptide (BNP) and hemodynamics was investigated. Stepwise multivariate regression analysis was used to determine which variables closely correlated with cardiac MIBG parameters. There was a significant increase in the NE level between the Ao (446 pg/ml) and the CS (727 pg/ml). According to stepwise multivariate regression analysis, the heart/mediastinum (H/M) ratio independently correlated with the transcardiac gradient of BNP (r=-0.480, pJpn Circ J 2001; 65: 1041 - 1046)Keywords
This publication has 33 references indexed in Scilit:
- Comparison of parameters of 123I-MIBG scintigraphy for predicting prognosis in patients with dilated cardiomyopathyNuclear Medicine Communications, 1999
- Cardiac metaiodobenzylguanidine uptake in patients with moderate chronic heart failure: relationship with peak oxygen uptake and prognosisJournal of Invasive Cardiology, 1999
- Cardiac death prediction and impaired cardiac sympathetic innervation assessed by MIBG in patients with failing and nonfailing heartsJournal of Nuclear Cardiology, 1998
- Use of iodine-123 metaiodobenzylguanidine myocardial imaging to predict the effectiveness of ?-blocker therapy in patients with dilated cardiomyopathyEuropean Journal of Nuclear Medicine and Molecular Imaging, 1997
- Iodine-123 metaiodobenzylguanidine myocardial scintigraphy for prediction of response to β-blocker therapy in patients with dilated cardiomyopathyAmerican Heart Journal, 1997
- Iodine-123 metaiodobenzylguanidine images reflect intense myocardial adrenergic nervous activity in congestive heart failure independent of underlying causeJournal of Invasive Cardiology, 1995
- Prognostic value of plasma soluble intercellular adhesion molecule-1 and endothelin-1 concentration in patients with chronic congestive heart failureThe American Journal of Cardiology, 1995
- Myocardial β-Adrenergic Desensitization and Neuronal Norepinephrine Uptake Function in Idiopathic Dilated CardiomyopathyJournal of Cardiovascular Pharmacology, 1992
- Neurohormonal interactions and adaptations in congestive heart failure.Journal of the American College of Cardiology, 1988
- Plasma Norepinephrine as a Guide to Prognosis in Patients with Chronic Congestive Heart FailureThe New England Journal of Medicine, 1984